We obtained clinical and molecular data from 296 patients with BRAF-altered glioma (151 males, 145 females), including 206 adults (median 43 years, range 18–85 years) and 90 children (age <18 years, median 10 years, range 0–17 years). The gene discussed is BRAF; the disease is central nervous system cancer.